Alisa Lu
Associate, Washington, D.C.
Alisa Lu
Associate, Washington, D.C.
Alisa Lu is an associate in Cohen & Gresser’s Washington, D.C. office. Alisa’s practice focuses on commercial litigation and antitrust. She has experience advising companies on competition matters, including advising companies on receiving merger clearance. Alisa also has experience representing financial institutions in civil proceedings in federal and state courts. She has been recognized in The Legal 500‘s U.S. coverage in the civil litigation/class actions defense category, and Super Lawyers has recognized her as a Rising Star for business litigation.
Prior to joining Cohen & Gresser, Alisa was an associate at Sullivan & Cromwell. She also served as a Law Clerk to the Honorable Peter J. Messitte of the U.S. District Court for the District of Maryland.
Before attending law school, Alisa was an analyst at J.P. Morgan in New York in the Corporate & Investment Bank.
Alisa is a graduate of Harvard Law School, where she was the managing editor of the Harvard Journal on Legislation. She received a Bachelor of Arts in Financial Economics and Political Science from Columbia University.
Alisa Lu is an associate in Cohen & Gresser’s Washington, D.C. office. Alisa’s practice focuses on commercial litigation and antitrust. She has experience advising…
Education
Harvard Law School (J.D., cum laude, 2018); Columbia University (B.A., cum laude, 2013)
Bar Admissions
District of Columbia; State of New York; U.S. Court of Appeals for the Fourth Circuit; U.S. District Court for the District of Maryland
Mark Cohen is once again recognized as a Leading Partner in both Securities Litigation and Corporate Investigations & White-Collar Crime: Advice to Individuals.
The 2024 guide also recognizes Lawrence T. Gresser, Jonathan Abernethy, Jason Brown, S. Gale Dick, Christian Everdell, Jeffrey Lang, Alisa Lu, Melissa Maxman, Douglas Pepe, John Roberti, Daniel Tabak, and Ronald Wick as recommended lawyers.
This 17th edition of The Legal 500 United States guide, which identifies the “true superstars of the profession,” involved a detailed assessment of various factors, including work conducted by law firms over the past 12 months and historically; experience and depth of teams; and client feedback.
Founded in 2002, Cohen & Gresser’s New York office serves as the firm’s headquarters. Our New York attorneys are particularly strong in complex litigation, investigations, and transactions. The firm’s Washington, D.C. office handles a range of commercial litigation and regulatory enforcement actions, with a focus on domestic and foreign antitrust issues.
Each year, Super Lawyers identifies outstanding lawyers nationwide and regionally who have attained a high degree of peer recognition and professional achievement. Only 5 percent of lawyers are selected as Super Lawyers, and only 2.5 percent are selected as Rising Stars. This latest guide recognizes 100 percent of our D.C. partners and associates.
The C&G lawyers recognized as Washington, D.C. Super Lawyers are:
- Melissa H. Maxman – Antitrust Litigation
- John Roberti – Antitrust Litigation
- Ronald F. Wick – Antitrust Litigation
The C&G lawyers recognized as Washington, D.C. Rising Stars are:
- Derek Jackson – Business Litigation
- Alisa Lu – Business Litigation
- Last month, the FTC released a new policy statement noting its broadened view of the scope of its power under Section 5 of the FTC Act, signaling that it may find certain private equity rollups violate its interpretation.
- The FTC policy statement came on the heels of a DOJ announcement that it would be increasing the enforcement of Section 8 of the Clayton Act.
- These developments underscore the need for private equity companies to take particular care in observing U.S. competition laws, as there will be greater scrutiny of private equity firms.
In this client alert, Melissa Maxman, Ronald Wick, and Alisa Lu analyze what these actions mean for the future of antitrust enforcement in the private equity sector and provide insight into how PE firms can prepare themselves for continued additional scrutiny.